As a result, NF‐1 treatment can convert “cold” tumors into “hot” tumors by reshaping the MIF‐mediated immunosuppressive network, NF‐1 treatment thus enabling effective immunotherapy in BRCA and enhancing the ICB efficacy in colon adenocarcinoma (COAD). This evidence concerns the gene NF1 and colon adenocarcinoma.